ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

TEMRA CD8 T Cells from Kidney Transplant Recipients Exhibit Enhanced Purinergic P2x4 Receptor-Dependent Proinflammatory and Migratory Responses

G. Tilly1, T. Doan-Ngoc1, O. Bonizec1, C. Masset2, R. Danger3, P. Guérif1, S. Bruneau1, J. Harb1, M. Giral1, C. Pecqueur4, S. Brouard1, N. Degauque1

1Nantes Université, CHU Nantes, Inserm, Centre de Recherche en Transplantation et Immunologie, UMR 1064, ITUN, Nantes, France, 2University Hospital of Nantes, Nantes, France, 3CRTI- INSERM UMR 1064, Nantes, France, 4Nantes Université, Univ Angers, INSERM, CNRS, CRCINA, F-44000 Nantes, Nantes, France

Meeting: 2022 American Transplant Congress

Abstract number: 571

Keywords: Adhesion molecules, Kidney transplantation, T cells

Topic: Basic Science » Basic Clinical Science » 19 - Chronic Organ Rejection

Session Information

Session Name: Chronic Organ Rejection

Session Type: Rapid Fire Oral Abstract

Date: Tuesday, June 7, 2022

Session Time: 5:30pm-7:00pm

 Presentation Time: 5:30pm-5:40pm

Location: Hynes Room 309

*Purpose: Whereas the role of effector memory and TEMRA CD8 in allotransplantation has been clearly evidenced and particularly the direct correlation between intragraft infiltrating CD8 and rejection, the mechanisms regulating the migration of CD8 T cells to nonlymphoid tissue during inflammation have not been fully elucidated, and the migratory properties of effector memory (EM) re-expressing CD45RA (namely, TEMRA) CD8 are still unclear.

*Methods: Adhesion of EM and TEMRA CD8 from Kidney Transplant Recipient (KTx) and Healthy Volunteers (HV) to primary endothelial cell line, their transmigration, and time-lapse microscopy were used and the underlying mechanism was investigated using blocking antibodies and small inhibitory molecules. Activation (CD25, CD69; calcium flux) and cytotoxic function (CD107a) of EM and TEMRA CD8 were measured in response to chemokine CXCL12 stimulation and the role of purinergic receptor (P2XR1,4 and 7) were assessed.

*Results: Using static and dynamic models, we showed that after transplantation, the migratory fitness of TEMRA CD8 are enhanced compared to effector memory (EM) CD8, with enhanced adhesion to activated endothelium, a stronger ability to transmigrate across a monolayer of activated endothelial cells in response to CXCL12 and stronger patrolling behavior. In contrast, after transplantation, the migratory properties of TEMRA CD8 were very similar to those of TEMRA and EM CD8 purified from HV. Whereas the blockade of the interaction between functional PSGL1 and P-selectin prevent the adhesion and transmigration of TEMRA and EM CD8 from KTx, only TEMRA CD8 were susceptible to LFA-1 blockade. We found that the chemokine CXCL12 directly triggers a stimulatory signal involving an increase in cytosolic Ca2+ and a Panx1-dependent release of extracellular ATP, leading to autocrine stimulation of the purinergic receptor P2X4. Finally, we found that TEMRA CD8 from KTx exhibit a greater functional response as compared to EM CD8 upon CXCL12 stimulation

*Conclusions: Our findings suggest that therapeutic strategies such as LFA-1 blockade or impairing functional PGSL-1 could prevent TEMRA CD8 migration and activation and be directedly beneficial to patients with allotransplantation.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Tilly G, Doan-Ngoc T, Bonizec O, Masset C, Danger R, Guérif P, Bruneau S, Harb J, Giral M, Pecqueur C, Brouard S, Degauque N. TEMRA CD8 T Cells from Kidney Transplant Recipients Exhibit Enhanced Purinergic P2x4 Receptor-Dependent Proinflammatory and Migratory Responses [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/temra-cd8-t-cells-from-kidney-transplant-recipients-exhibit-enhanced-purinergic-p2x4-receptor-dependent-proinflammatory-and-migratory-responses/. Accessed May 29, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences